ID   TEC-4
SY   1G4; TEC4; Tumor endothelial cell antibody 4
DR   ATCC; HB-12312
DR   Wikidata; Q108821367
RX   Patent=US5660827;
RX   Patent=US5877289;
RX   PubMed=9815965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12312.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD195.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
RX   Patent=US5660827;
RA   Thorpe P.E., Burrows F.J.;
RT   "Antibodies that bind to endoglin.";
RL   Patent number US5660827, 26-Aug-1997.
RX   Patent=US5877289;
RA   Thorpe P.E., Edgington T.S.;
RT   "Tissue factor compositions and ligands for the specific coagulation
RT   of vasculature.";
RL   Patent number US5877289, 02-Mar-1999.
RX   PubMed=9815965;
RA   Burrows F.J., Derbyshire E.J., Tazzari P.L., Amlot P., Gazdar A.F.,
RA   King S.W., Letarte M., Vitetta E.S., Thorpe P.E.;
RT   "Up-regulation of endoglin on vascular endothelial cells in human
RT   solid tumors: implications for diagnosis and therapy.";
RL   Clin. Cancer Res. 1:1623-1634(1995).